Literature DB >> 23572383

Contribution of Aurora-A and -B expression to DNA aneuploidy in gastric cancers.

Kenichi Honma1, Ryota Nakanishi, Tomonori Nakanoko, Koji Ando, Hiroshi Saeki, Eiji Oki, Makoto Iimori, Hiroyuki Kitao, Yoshihiro Kakeji, Yoshihiko Maehara.   

Abstract

PURPOSE: DNA aneuploidy, which is characterized by cells containing an abnormal number of chromosomes, is closely associated with carcinogenesis and malignant progression. Aneuploidy occurs during cell division when the chromosomes do not separate properly. Aurora kinases (Aurora-A, -B, and -C) contribute to accurate cell division, and are candidate molecular targets for mitosis-specific anticancer drugs.
METHODS: We determined the expression of Aurora-A and -B in 110 gastric cancer specimens by performing an immunohistochemical analysis. We also determined the DNA content, TP53 gene mutations, and microsatellite instability in the same samples.
RESULTS: We found the nuclear expression of Aurora-A and -B to increase in tumor tissue in comparison to that in normal epithelial tissue. A high Aurora-B expression significantly correlated with aneuploidy and TP53 mutations, but not with microsatellite instability. In contrast, the Aurora-A expression did not correlate with either aneuploidy or microsatellite instability. In addition, the expression of Aurora-A or -B was not significantly associated with the clinical outcomes or prognosis.
CONCLUSIONS: Our results suggest that an overexpression of Aurora-B, but not of Aurora-A, might contribute to DNA aneuploidy in gastric cancers by promoting chromosomal instability.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23572383     DOI: 10.1007/s00595-013-0581-x

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  42 in total

Review 1.  Mechanisms of chromosomal instability.

Authors:  Sarah L Thompson; Samuel F Bakhoum; Duane A Compton
Journal:  Curr Biol       Date:  2010-03-23       Impact factor: 10.834

2.  Sample preparation from paraffin-embedded tissue specimens for laser scanning cytometric DNA analysis.

Authors:  T Kamada; K Sasaki; T Tsuji; T Todoroki; M Takahashi; A Kurose
Journal:  Cytometry       Date:  1997-03-01

Review 3.  Aneuploidy and cancer.

Authors:  S Sen
Journal:  Curr Opin Oncol       Date:  2000-01       Impact factor: 3.645

4.  Frequency of microsatellite instability inBreast cancer determined by high-resolution fluorescent microsatellite analysis.

Authors:  E Tokunaga; E Oki; S Oda; A Kataoka; K Kitamura; S Ohno; Y Maehara; K Sugimachi
Journal:  Oncology       Date:  2000-06       Impact factor: 2.935

5.  Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.

Authors:  Bibo Yuan; Yi Xu; Ju-Hyung Woo; Yunyue Wang; Young Kyung Bae; Dae-Sung Yoon; Robert P Wersto; Ellen Tully; Kathleen Wilsbach; Edward Gabrielson
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

6.  Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation.

Authors:  X Wang; Y-X Zhou; W Qiao; Y Tominaga; M Ouchi; T Ouchi; C-X Deng
Journal:  Oncogene       Date:  2006-05-22       Impact factor: 9.867

7.  BubR1 and AURKB overexpression are associated with a favorable prognosis in gastric cancer.

Authors:  Megumu Enjoji; Satoru Iida; Hirofumi Sugita; Toshiaki Ishikawa; Hiroyuki Uetake; Mikito Inokuchi; Hiroyuki Yamada; Kazuyuki Kojima; Kenichi Sugihara
Journal:  Mol Med Rep       Date:  2009 Jul-Aug       Impact factor: 2.952

8.  Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients.

Authors:  Yi-Jen Chen; Chun-Ming Chen; Nae-Fang Twu; Ming-Shyen Yen; Chiung-Ru Lai; Hua-Hsi Wu; Peng-Hui Wang; Chiou-Chung Yuan
Journal:  Virchows Arch       Date:  2009-10-17       Impact factor: 4.064

Review 9.  Chromosome aberrations in solid tumors.

Authors:  Donna G Albertson; Colin Collins; Frank McCormick; Joe W Gray
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

10.  Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.

Authors:  Claire Ditchfield; Victoria L Johnson; Anthony Tighe; Rebecca Ellston; Carolyn Haworth; Trevor Johnson; Andrew Mortlock; Nicholas Keen; Stephen S Taylor
Journal:  J Cell Biol       Date:  2003-04-28       Impact factor: 10.539

View more
  12 in total

1.  Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.

Authors:  Po Zhao; Yali Lu; Lin Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

2.  AURKB Promotes the Metastasis of Gastric Cancer, Possibly by Inducing EMT.

Authors:  Zhen Wang; Zhu Yu; Gong-He Wang; Yi-Ming Zhou; Jian-Ping Deng; Yue Feng; Jun-Qiang Chen; Lei Tian
Journal:  Cancer Manag Res       Date:  2020-08-05       Impact factor: 3.989

Review 3.  Aurora B kinase: a potential drug target for cancer therapy.

Authors:  Azaj Ahmed; Anas Shamsi; Taj Mohammad; Gulam Mustafa Hasan; Asimul Islam; Md Imtaiyaz Hassan
Journal:  J Cancer Res Clin Oncol       Date:  2021-05-28       Impact factor: 4.553

4.  RNA interference-mediated knockdown of Aurora-B alters the metastatic behavior of A549 cells via modulation of the phosphoinositide 3-kinase/Akt signaling pathway.

Authors:  Long Dian Zhou; Xu Xiong; Xin Hua Long; Zhi Li Liu; Shan Hu Huang; Wei Zhang
Journal:  Oncol Lett       Date:  2014-08-20       Impact factor: 2.967

5.  Excess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivo.

Authors:  S Winsel; J Mäki-Jouppila; M Tambe; M R Aure; S Pruikkonen; A-L Salmela; T Halonen; S-K Leivonen; L Kallio; A-L Børresen-Dale; M J Kallio
Journal:  Br J Cancer       Date:  2014-09-30       Impact factor: 7.640

6.  Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer.

Authors:  H Liu; J Lu; Y Hua; P Zhang; Z Liang; L Ruan; C Lian; H Shi; K Chen; Z Tu
Journal:  Cell Death Dis       Date:  2015-01-15       Impact factor: 8.469

7.  Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases.

Authors:  Wang Liu; Yu Lu; Xiaoping Chai; Xiao Liu; Tong Zhu; Xihan Wu; Yanfen Fang; Xuan Liu; Xiongwen Zhang
Journal:  J Exp Clin Cancer Res       Date:  2016-11-25

Review 8.  Aurora kinases: novel therapy targets in cancers.

Authors:  Anqun Tang; Keyu Gao; Laili Chu; Rui Zhang; Jing Yang; Junnian Zheng
Journal:  Oncotarget       Date:  2017-04-04

9.  Overexpression of PRC1 indicates a poor prognosis in ovarian cancer.

Authors:  Hualei Bu; Yingwei Li; Chengjuan Jin; Hongfeng Yu; Xiangxiang Wang; Jingying Chen; Yu Wang; Yana Ma; Youzhong Zhang; Beihua Kong
Journal:  Int J Oncol       Date:  2020-01-10       Impact factor: 5.650

10.  The evolution of surgical treatment for gastrointestinal cancers.

Authors:  Yoshihiko Maehara; Yuji Soejima; Tomoharu Yoshizumi; Naoyuki Kawahara; Eiji Oki; Hiroshi Saeki; Tomohiko Akahoshi; Toru Ikegami; Yo-Ichi Yamashita; Tadashi Furuyama; Keishi Sugimachi; Noboru Harada; Tetsuzo Tagawa; Norifumi Harimoto; Shinji Itoh; Hideto Sonoda; Koji Ando; Yuichiro Nakashima; Yoshihiro Nagao; Nami Yamashita; Yuta Kasagi; Takafumi Yukaya; Takeshi Kurihara; Ryosuke Tsutsumi; Shinkichi Takamori; Shun Sasaki; Tetsuo Ikeda; Yoshikazu Yonemitsu; Takasuke Fukuhara; Hiroyuki Kitao; Makoto Iimori; Yuki Kataoka; Takeshi Wakasa; Masami Suzuki; Koji Teraishi; Yasuto Yoshida; Masaki Mori
Journal:  Int J Clin Oncol       Date:  2019-09-14       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.